Saluda Medical Funding: $664M Raised, Series U (2025)
Saluda Medical is based in Artarmon, Nsw, Australia. It has raised $664M in total funding. Latest round: Series U.
Saluda Medical funding overview
Saluda Medical is based in Artarmon, Nsw, Australia. Saluda Medical has raised $664M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series U announced in January 2025. The round record for Saluda Medical runs through 2025; nothing later has been disclosed. Investors on record include Redmile Group, Boston Scientific, BioScience Managers, Medtronic, Action Potential Venture Capital, Wellington Management and 4 others. 10 distinct backers are named across the disclosed rounds.
Saluda Medical at a glance
Total raised
$664M
Latest round
Series U
Latest round date
January 2025
Headquarters
Artarmon, Nsw, Australia
Notable investors
Redmile Group, Boston Scientific, BioScience Managers, Medtronic, Action Potential Venture Capital, Wellington Management, RA Capital, Seventure Partners
Frequently asked about Saluda Medical funding
How much has Saluda Medical raised?
Saluda Medical has raised $664M in total disclosed funding across the rounds on record.
Who has invested in Saluda Medical?
Redmile Group, Boston Scientific, BioScience Managers, Medtronic, Action Potential Venture Capital, Wellington Management are named among the investors backing Saluda Medical.
What was the latest Saluda Medical funding round?
The most recent disclosed round is a Series U, announced in January 2025.
Where is Saluda Medical based?
Saluda Medical is based in Artarmon, Nsw, Australia.
When did Saluda Medical last raise?
The last disclosed Saluda Medical round closed in January 2025 at Series U.
We update the Saluda Medical record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Artarmon and their backers are listed below.
